Clinical Trial Update: Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates Phase 1/Phase 2 studies are investigating intravenous immunoglobulin–based therapy targeting collagen VII antibodies for dystr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophic Epidermolysis Bullosa
• Epidermolysis Bullosa
• Epidermolysis Bullosa Acquisita
• Recessive Dystrophic Epidermolysis Bullosa

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: M. Peter Marinkovich | Conditions: Epidermolysis Bullosa, Epidermolysis Bullosa Acquisita | Phase 1, Phase 2 | Status: RECRUITING